The Ozempic Enigma: Where Physical Benefits Meet Social Uncertainty The rapid growth of GLP 1 medications like Ozempic has transformed the treatment landscape for diabetes patients, delivering significant physical health benefits that have made them a favorite among both patients and healthcare providers.
However, as insurers and government programs consider expanding access to these medications, researchers are sounding a note of caution: while they may change your body, it's unclear whether they can change your life in meaningful ways.
A recent study published by University of Chicago economist Robert Kaestner and coauthor Cuiping Schiman offers insight into this uncertainty.